Vancouver, British Columbia--(Newsfile Corp. - November 22, 2021) - Entheon Biomedical Corp. (CSE: ENBI) - Researching and developing DMT, one of the most powerful psychedelics in existence, to address substance use disorders related to nicotine, alcohol, and opioids.

If you cannot view the video above, please visit:
https://b-tv.com/investor-alert-entheon-biomedical-treating-addiction-btv-investing-news/

Entheon Biomedical Corp. is being featured on BNN Bloomberg on Nov 22nd to Dec 5th, 2021, throughout the day and evenings.

Entheon Biomedical Corp. (CSE: ENBI)

https://entheonbiomedical.com/

About BTV:

BTV-Business Television is Canada's longest running business show. With Hosts Taylor Thoen and Jessica Katrichak, BTV features emerging companies across the country to bring viewers investment opportunities. BTV also produces News Alerts and branding/ awareness spots for issuers broadcast on BNN Bloomberg, Fox Business News, Bloomberg TV US and Bloomberg Terminals. www.b-tv.com

BTV - Business Television/CEO Clips Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/104650